Navigation Links
Insulet Corporation to Report Third Quarter 2007 Financial Results on Wednesday, November 14th
Date:11/7/2007

BEDFORD, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod(R) Insulin Management System, announced plans to release its financial results for the third quarter 2007 on Wednesday, November 14, 2007 after the close of the financial markets.

Insulet will also host a conference call at 8:00 a.m. Eastern Time on Thursday, November 15, 2007 to discuss its third quarter 2007 financial results. During the conference call, material information concerning the Company, its operations, strategies and prospects may be discussed.

To listen to the conference call, please dial 800.688.0836 for domestic callers and 617.614.4072 for international callers. The passcode is 63605515. A replay of the conference call will be available two hours after the start of the call through December 15, 2007 by dialing 888-286-8010 (domestic) and 617-801-6888 (international), passcode 89284526. An online archive of the conference call will also be available by accessing the Investor Information section of the company's website at http://investors.insulet.com.

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully- automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in
'/>"/>

SOURCE Insulet Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program
2. Insulet Corporation Announces Pricing of Secondary Public Offering
3. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
4. Brooke Franchise Corporation Announces Selected July Results
5. MedThink Communications Retained by NanoBio Corporation
6. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
7. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
8. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
9. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
10. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
11. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2008)...ge, MA...Free prescription drug samples distribute...by physicians from Cambridge Health Alliance and H... first to look at free drug sample use among child...ics . , The authors, who also serve as research...t Medical School of Brown University, found that c...
(Date:10/5/2008)...ss. (October 6, 2008) Asthmatic children whose pa...function normally are less likely to have symptoms...ccording to a new study. Children also are more li...ately if they have a routine for taking medicine a...mptoms can be controlled. , The study, which app...
(Date:10/3/2008)...ties, the corner store, with its chips, soda and c...od residents, but also researchers are discovering... Researchers from Temple University and The Food ... children before and after school as part of a lar... Their findings will be presented at The Obesity S...
(Date:10/3/2008)...a Joins Nationwide Komen Community Challenge Campa...lier for Low-Income Women and Women of .../PRNewswire/ -- Pennsylvania House Speaker Dennis,...d breast cancer survivors,and advocates from the P...re(R) at a public forum this morning to call for p...
Breaking Medicine News(10 mins):Health News:Free drug samples carry risks for children 2Health News:Children's asthma affected by parental expectations 2Health News:Corner stores capture kids on morning commute 2Health News:Susan G. Komen for the Cure(R), Speaker Dennis O'Brien, Obama and McCain Health Care Advisors, Breast Cancer Survivors and Advocates Call for Needed Health Care Reforms 2Health News:Susan G. Komen for the Cure(R), Speaker Dennis O'Brien, Obama and McCain Health Care Advisors, Breast Cancer Survivors and Advocates Call for Needed Health Care Reforms 3
...Human induced nitrogen deposition is indirectly "f...equestering major amounts of carbon, a joint study...nada and Europe, has revealed. Researchers say the...of the carbon cycle in forests. Earlier it was kn...
...Angelina Jolie insists that vanity is not the reas...ew months, and that her grief over her mothers dea...he New York premiere of her new movie A Mighty Hea...is because shes not only still grieving over the l...
...A new study suggests that getting some extra sleep...athletic performance. Researcher Cheri Mah and c...thy male college basketball players. They were t...sual sleeping habits for two weeks and in the foll...
...A new study has found that obesity, high blood pre...ing problem in college students in age group of 18...rchers including Ingrid Lofgren, Joanne Burke, Rut...ell, at the University of New Hampshire. As part ...
Other Medicine News:Health News:Human Induced Nitrogen Deposition Increasing Carbon Sequestration in Forests 2
(Date:10/2/2008)...harmaleads has obtained from the,French Medicine A...gle,ascending dose Phase I study with PL37, its le...., Neuropathic pain is a major chronic pain condi...population of up to 6%, according to the most,rece...pes, diabetes,antiviral or antitumor chemotherapy...
(Date:10/2/2008)...rstCall/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ; ...sed on,endocrine therapy and oncology, today repor...t recruitment for its Phase 2 trial in ovarian can... hormone (LHRH) agonist,linked to doxorubicin. The...ruitment was taken following recent first stage da...
(Date:10/1/2008)... of Amylin,s integrated neurohormonal ...GO, Oct. 1 /- Amylin Pharma...hat new data for its pipeline obesity,candidates w...ting of The,Obesity Society in Phoenix October 3-7...he largest and most comprehensive scientific confe...
(Date:10/1/2008)...unoVaccine Technologies, (IVT),patented depot vacc...re-clinical results, with single-dose efficacy ach... disease vaccine models. The results of this,resea...I conference in,Germany. Collaborators from the Un...pabilities of IVT,s depot formulations for deliver...
Breaking Medicine Technology:Pharmaleads' Lead Candidate for Pain, PL37, Enters Phase I 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 2Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 3Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 4Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 5Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 6Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 7ImmunoVaccine Technologies' DepoVax(TM) Shows Positive Results for Cancer and Infectious Diseases 2New book further supports controversial theory of Man the Hunted 4547 1New book further supports controversial theory of Man the Hunted 4547 2New book further supports controversial theory of Man the Hunted 4547 3New book further supports controversial theory of Man the Hunted 4547 4New book further supports controversial theory of Man the Hunted 4547 5Service and Hardware Revenues Will Contribute 241 8 Billion to the U S Eldercare Industry by 2013 25612 1Service and Hardware Revenues Will Contribute 241 8 Billion to the U S Eldercare Industry by 2013 25612 2New insights into the regulation of PTEN tumor suppression function 4545 1New insights into the regulation of PTEN tumor suppression function 4545 2Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 4543 1Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 4543 2Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 4543 3
...e to Advance Clinical and Regulatory Development o...May 22, 2007 /PRNewswire-FirstCall/ -- Celgene,Cor...pment of,leading oral anti-inflammatory candidates...-10004 (apremilast), an oral TNF,antagonist and an...,activity and an excellent side effect profile in ...
...RN, Pa., May 22, 2007 /PRNewswire-FirstCall/ -- Au...new data show,improvements in symptoms of decrease...6 percent of hypogonadal men after switching,brand...estosterone,levels increased significantly in pati...osterone gel) following suboptimal,response to Sol...
Other Medicine Technology:Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 2Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 3Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 4Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 2Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 3Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 4Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 5
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort.
Freedom leg bags are part of the Freedom Urinary Collection Systems: a versatile line of leg bags, kits, and accessories designed to meet the varied needs of our customers. These leg bags are offered
It's easy on delicate urethral tissues. The gentle, silicone design and hydrophilic coating provide nearly friction-free movement, without a lubricating gel. It's easy to maintain sterility. You simp
Freedom leg bags are part of the Freedom Urinary Collection Systems: a versatile line of leg bags, kits, and accessories designed to meet the varied needs of our customers. These leg bags are offered
Medicine Products: